文献速递中毒与环境急症复苏、休克与脓毒症

高剂量胰岛素用于β受体阻滞剂和钙通道阻滞剂中毒

High dose insulin for beta-blocker and calcium channel-blocker poisoning.
PubMed 文献 · Am J Emerg Med · 2018-02-06
一句话结论对β受体阻滞剂或钙通道阻滞剂所致休克,中毒中心常规推荐高剂量胰岛素从1U/kg/h起始并滴定至10U/kg/h,该大样本病例系列显示可行且安全,但低钾血症和低血糖常见。

本研究为结构化病历回顾,纳入199例因β受体阻滞剂(BB)或钙通道阻滞剂(CCB)中毒接受高剂量胰岛素(HDI,定义为胰岛素输注≥0.5U/kg/h)的患者。中位年龄48岁,44%为BB中毒,33%为CCB中毒,23%为两者兼有。41例(21%)发生心脏骤停,31例(16%)死亡。低钾血症发生率29%,低血糖发生率31%;当葡萄糖维持输注浓度≤10%时低血糖发生率为50%(29/50),当浓度≥20%时为30%(31/105)。结论认为,由急诊医师在中毒中心会诊下启动的HDI在该大样本系列中可行且安全,代谢异常常见,需密切监测。

要点

  • 中毒中心常规推荐对BB或CCB所致休克使用HDI,从1U/kg/h起始并滴定至10U/kg/h。
  • 199例患者中,中位起始胰岛素输注为1U/kg/h,中位峰值输注为8U/kg/h(范围0.5-18)。
  • 低血糖总发生率31%;葡萄糖维持输注浓度≤10%时低血糖发生率50%(29/50),≥20%时为30%(31/105)。
  • 低钾血症发生率29%,代谢异常常见,需密切监测。
  • 41例(21%)发生心脏骤停,31例(16%)死亡。

适用人群与场景

  • 因β受体阻滞剂或钙通道阻滞剂中毒接受高剂量胰岛素(HDI,定义为胰岛素输注≥0.5U/kg/h)的患者,年龄范围14-89岁。

诊断标准与关键阈值

  • HDI定义为胰岛素输注≥0.5U/kg/h。

处置流程与药物剂量

  • 中毒中心常规推荐对BB或CCB所致休克使用HDI,从1U/kg/h起始并滴定至10U/kg/h。
  • 中位胰岛素推注剂量为1U/kg(范围0.5-10)。
  • 中位起始胰岛素输注为1U/kg/h(范围0.22-10),中位峰值输注为8U/kg/h(范围0.5-18)。

红旗征与不能漏的情况

  • 低血糖:总发生率31%;葡萄糖维持输注浓度≤10%时发生率50%(29/50),≥20%时发生率30%(31/105)。
  • 低钾血症:发生率29%。
  • 心脏骤停:41例(21%)发生。
  • 死亡:31例(16%)发生。

研究设计与关键结果

  • 研究类型为结构化病历回顾,纳入199例因BB或CCB中毒接受HDI的患者。
  • 中位年龄48岁(范围14-89),50%为男性;88例(44%)为BB中毒,66例(33%)为CCB中毒,45例(23%)为两者兼有。
  • 中位最低脉搏为54次/分(范围12-121),中位最低收缩压为70mmHg(范围30-167)。
  • 41例(21%)发生心脏骤停,31例(16%)死亡。
  • 低钾血症发生率29%,低血糖发生率31%;葡萄糖维持输注浓度≤10%时低血糖发生率50%(29/50),≥20%时30%(31/105)。

证据类型、等级与局限

  • 证据类型:结构化病历回顾。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 由急诊医师在中毒中心会诊下启动HDI在该大样本系列中可行且安全。
  • 代谢异常常见,需密切监测。
  • 使用较低浓度葡萄糖维持输注时低血糖更常见。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND/OBJECTIVES: High dose insulin (HDI) is a standard therapy for beta-blocker (BB) and calcium channel-blocker (CCB) poisoning, however human case experience is rare. Our poison center routinely recommends HDI for shock from BBs or CCBs started at 1U/kg/h and titrated to 10U/kg/h. The study objective was to describe clinical characteristics and adverse events associated with HDI.

METHODS: This was a structured chart review of patients receiving HDI for BB or CCB poisoning with HDI defined as insulin infusion of ≥0.5U/kg/h.

RESULTS: In total 199 patients met final inclusion criteria. Median age was 48years (range 14-89); 50% were male. Eighty-eight patients (44%) were poisoned by BBs, 66 (33%) by CCBs, and 45 (23%) by both. Median nadir pulse was 54 beats/min (range 12-121); median nadir systolic blood pressure was 70mmHg (range, 30-167). Forty-one patients (21%) experienced cardiac arrest; 31 (16%) died. Median insulin bolus was 1U/kg (range, 0.5-10). Median starting insulin infusion was 1U/kg/h (range 0.22-10); median peak infusion was 8U/kg/h (range 0.5-18). Hypokalemia occurred in 29% of patients. Hypoglycemia occurred in 31% of patients; 50% (29/50) experienced hypoglycemia when dextrose infusion concentration ≤10%, and 30% (31/105) experienced hypoglycemia when dextrose infusion concentration ≥20%.

CONCLUSIONS: HDI, initiated by emergency physicians in consultation with a poison center, was feasible and safe in this large series. Metabolic abnormalities were common, highlighting the need for close monitoring. Hypoglycemia was more common when less concentrated dextrose maintenance infusions were utilized.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Cole JB, Arens AM, Laes JR, et al. High dose insulin for beta-blocker and calcium channel-blocker poisoning. Am J Emerg Med. 2018. PMID: 29452919. doi:10.1016/j.ajem.2018.02.004

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。